Why cannabis company Althea is pushing higher today

The Althea Group Holdings Ltd (ASX:AGH) share price has raced higher today following a positive product update…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Althea Group Holdings Ltd (ASX: AGH) share price was out of form last week and sank notably lower.

The cannabis company's shares crashed almost 40% lower after one of its major shareholders sold off all their non-escrowed shares at a significant discount.

That shareholder was Canadian cannabis giant Aphria. It offloaded 37 million shares, which is the equivalent of 15.7% of the company's issued capital.

This was the second time this month that a cannabis giant has dumped its holding in an ASX-listed pot stock. Earlier this month Canopy Growth Corp sold 42 million shares in Auscann Group Holdings Ltd (ASX: AC8) for just 15 cents per share.

I can't help but feel that this is a very ominous sign for the local cannabis market.

However, that hasn't stopped some investors from buying Althea's shares this morning following a product update.

What has Althea announced?

This morning Althea announced the launch of Althea CBD100.

Althea CBD100 is a full spectrum cannabis-derived extract oral oil comprised predominantly of cannabidiol (CBD), along with small traces of terpenoids, flavonoids, and other cannabinoids.

It contains less than 1mg per ml of tetrahydrocannabinol (THC) and will be Althea's most highly concentrated CBD medicinal cannabis product.

Management believes Althea CBD100's full spectrum cannabinoid profile provides it with a competitive advantage over existing products in the market, which are generally purified or isolate CBD.

It is manufactured in Australia, GMP certified, and ready for export to international markets.

Althea Group Holdings CEO Josh Fegan said: "Launching Althea CBD100 fills an important gap in our existing product portfolio. Based on our extensive market research including discussions with various clinics, doctors and patients, we believe that Althea CBD100 will be well received in the marketplace. We are very proud of the fact Althea CBD100 is formulated and manufactured in Australia under GMP."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 managed a gain today, but only just.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why Evolution Mining, Macquarie, Ramsay, and SGH shares are pushing higher today

These shares are having a good session on Tuesday. Let's see what is getting investors excited.

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough start to the trading week this Monday.

Read more »

A steel worker peers out from under his protective headwear which is tipped back on his head as he stares solemnly straight ahead with steel production equipment in the background.
Share Gainers

Why is everyone talking about BlueScope Steel shares on Monday?

It seems Trump's tariffs have winners as well as losers...

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 300 healthcare stock just rocketed 20% on BIG earnings growth

Investors are piling into the ASX 300 healthcare stock on Monday. But why?

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Ansell, GQG, Mayne Pharma, and Star shares are charging higher today

These shares are starting the week on a positive note. But why?

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the trading week this Friday.

Read more »

Siblings jumping on a trampoline.
Share Gainers

These 3 ASX 200 stocks are charging higher this week. Own any?

Investors have been piling into these ASX 200 stocks this week. But why?

Read more »